Allianz Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-8,858
Closed -$551K 2278
2023
Q4
$551K Buy
8,858
+1,758
+25% +$98.3K ﹤0.01% 1825
2023
Q3
$398K Sell
7,100
-2,530
-26% -$142K ﹤0.01% 2002
2023
Q2
$486 Sell
9,630
-2,700
-22% -$144K ﹤0.01% 2087
2023
Q1
$673K Sell
12,330
-2,174
-15% -$127K ﹤0.01% 1814
2022
Q4
$907K Buy
+14,504
New +$962K ﹤0.01% 1556
2022
Q3
Sell
-62,844
Closed -$3.56M 2168
2022
Q2
$3.56M Sell
62,844
-183,928
-75% -$10.1M ﹤0.01% 1218
2022
Q1
$15.4M Buy
246,772
+55,998
+29% +$3.02M 0.01% 839
2021
Q4
$10.7M Sell
190,774
-193,926
-50% -$11.9M 0.01% 975
2021
Q3
$25M Buy
384,700
+11,015
+3% +$752K 0.02% 644
2021
Q2
$23.7M Sell
373,685
-3,500
-0.9% -$207K 0.02% 579
2021
Q1
$22.6M Buy
377,185
+161,490
+75% +$8.78M 0.02% 579
2020
Q4
$10.8M Buy
215,695
+50,955
+31% +$2.39M 0.01% 817
2020
Q3
$8.41M Buy
164,740
+5,499
+3% +$230K 0.01% 822
2020
Q2
$5.59M Sell
159,241
-84,408
-35% -$2.91M 0.01% 1157
2020
Q1
$6.19M Buy
243,649
+88,435
+57% +$2.63M 0.01% 1055
2019
Q4
$4.3M Buy
+155,214
New +$3.7M ﹤0.01% 1554

Other funds holding AXNX

Allianz Asset Management's AXNX Position: Q1 2024 in Review

Allianz Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q1 2024, closing a stake of 8,858 shares — an estimated $551K sold.

Allianz Asset Management first reported a position in AXNX in Q4 2019 and held it in 16 quarters. The position peaked at $25M in Q3 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q1 2024.

  • Allianz Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allianz Asset Management sold 8,858 Axonics, Inc. Common Stock shares in Q1 2024, an estimated $551K.
  • Allianz Asset Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 16 quarters.
  • Allianz Asset Management's Axonics, Inc. Common Stock position peaked at $25M in Q3 2021.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q1 2024.

Based on Allianz Asset Management's 13F filing for Q1 2024, filed 14 May 2024.